Page 185 - RTCOG Annual Meeting 2021
P. 185

25.  Chirasophon  S,  Manchana  T,  Teerapakpinyo  C.  High-risk  epithelial  ovarian  cancer
                  patients for hereditary ovarian cancer. J Obstet Gynaecol Res. 2017;43:929-34.

                         26.  Manchana T, Phowthongkum P, Teerapakpinyo C. Germline mutations in Thai patients

                  with nonmucinous epithelial ovarian cancer. World J Clin Oncol. 2019;10:358-68.
                         27.  ACOG Practice Bulletin No. 147: Lynch syndrome. Obstet Gynecol. 2014;124:1042-54.

                         28.  National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Cancer

                  Stat  Facts:  Colorectal  cancer.  [Internet].    [cited  2021  April  12].  Available  from:
                  https://seer.cancer.gov/statfacts/html/colorect.html.

                         29.  National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Cancer

                  Stat  Facts:  Uterine  cancer.  [Internet].    [cited  2021  April  12].  Available  from:
                  https://seer.cancer.gov/statfacts/html/corp.html

                         30.  Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt  RW. ACG clinical

                  guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J
                  Gastroenterol. 2015;110:223-62; quiz 63.

                         31.  Walsh T, Casadei S, Lee MK, Pennil CC, Nord AS, Thornton AM, et al. Mutations in 12

                  genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively
                  parallel sequencing. Proc Natl Acad Sci U S A. 2011;108:18032-7.

                         32.  Song  H,  Cicek  MS,  Dicks  E,  Harrington  P,  Ramus  SJ,  Cunningham  JM,  et  al.  The

                  contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes
                  to ovarian cancer in the population. Hum Mol Genet. 2014;23:4703-9.

                         33.  Vasen  HF,  Watson  P,  Mecklin  JP,  Lynch  HT.  New  clinical  criteria  for  hereditary

                  nonpolyposis  colorectal  cancer  (HNPCC,  Lynch  syndrome)  proposed  by  the  International
                  Collaborative group on HNPCC. Gastroenterology. 1999;116:1453-6.

                         34.  Syngal S, Fox EA, Eng C, Kolodner RD, Garber JE. Sensitivity and specificity of clinical

                  criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J
                  Med Genet. 2000;37:641-5.

                         35.  Barnetson RA, Tenesa A, Farrington SM, Nicholl ID, Cetnarskyj R, Porteous ME, et al.

                  Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer.
                  N Engl J Med. 2006;354:2751-63.







                  Genetic related gynecologic disorders and genetic testing                                 168
   180   181   182   183   184   185   186   187   188   189   190